Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study. by Gomo, Z, Hakim, J, Walker, SA, Tinago, W, Mandozana, G, Kityo, C, Munderi, P, Katabira, E, Reid, A, Gibb, D, Gilks, C

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy. by Bwakura-Dangarembizi, M, Musiime, V, Szubert, A, Prendergast, A, Gomo, Z, Thomason, M, Musarurwa, C, Mugyenyi, P, Nahirya, P, Kekitiinwa, A, Gibb, D, Walker, A, Nathoo, K